Orient EuroPharma Co., Ltd. (TPEX: 4120)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.10
+0.90 (1.91%)
Dec 20, 2024, 1:30 PM CST

Orient EuroPharma Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
4,4714,5924,7304,7675,3846,093
Upgrade
Revenue Growth (YoY)
-4.12%-2.93%-0.77%-11.45%-11.65%10.58%
Upgrade
Cost of Revenue
2,3052,4452,6982,6162,9623,279
Upgrade
Gross Profit
2,1652,1472,0322,1512,4222,815
Upgrade
Selling, General & Admin
1,7831,8681,9221,9181,938751.86
Upgrade
Research & Development
262.45206.6259.84331.09366.56394.6
Upgrade
Operating Expenses
2,0472,0772,1822,2462,3052,478
Upgrade
Operating Income
118.770.61-149.54-95.68117.36336.41
Upgrade
Interest Expense
-108.22-106.1-69.53-38.04-30.23-24.92
Upgrade
Interest & Investment Income
56.0450.8620.9611.8516.0420.22
Upgrade
Earnings From Equity Investments
-25.4-18.27-30.14-19.14-16.88-8.13
Upgrade
Currency Exchange Gain (Loss)
88.77-25.59-177.5111.6125.6312.96
Upgrade
Other Non Operating Income (Expenses)
67.0650.0840.5441.6936.4526.95
Upgrade
EBT Excluding Unusual Items
196.9521.6-365.23-87.71248.36363.5
Upgrade
Gain (Loss) on Sale of Assets
229.47234.572.35182.381.071.49
Upgrade
Asset Writedown
-12.52--35.3-10--
Upgrade
Other Unusual Items
1.80.160.050.10.460.02
Upgrade
Pretax Income
415.69256.25-328.1484.77249.88365.01
Upgrade
Income Tax Expense
161.0486.97-32.7710.47143.01228.23
Upgrade
Earnings From Continuing Operations
254.65169.29-295.3774.3106.88136.78
Upgrade
Minority Interest in Earnings
-63.75-25.34-15.4445.8892.43110.89
Upgrade
Net Income
190.91143.94-310.8120.17199.3247.66
Upgrade
Net Income to Common
190.91143.94-310.8120.17199.3247.66
Upgrade
Net Income Growth
----39.70%-19.53%0.38%
Upgrade
Shares Outstanding (Basic)
878787878787
Upgrade
Shares Outstanding (Diluted)
878787878787
Upgrade
Shares Change (YoY)
0.23%0.23%-0.24%-0.21%0.07%-0.03%
Upgrade
EPS (Basic)
2.201.66-3.581.392.302.86
Upgrade
EPS (Diluted)
2.201.66-3.581.382.292.84
Upgrade
EPS Growth
----39.74%-19.37%0.35%
Upgrade
Free Cash Flow
-50.6921.58-857.91-1,485375.77102.39
Upgrade
Free Cash Flow Per Share
-0.580.25-9.89-17.084.311.18
Upgrade
Dividend Per Share
1.0001.000-0.8501.5001.800
Upgrade
Dividend Growth
----43.33%-16.67%0%
Upgrade
Gross Margin
48.44%46.76%42.96%45.12%44.99%46.19%
Upgrade
Operating Margin
2.66%1.54%-3.16%-2.01%2.18%5.52%
Upgrade
Profit Margin
4.27%3.13%-6.57%2.52%3.70%4.06%
Upgrade
Free Cash Flow Margin
-1.13%0.47%-18.14%-31.15%6.98%1.68%
Upgrade
EBITDA
281.85235.757.0460.33278.32484.04
Upgrade
EBITDA Margin
6.30%5.13%0.15%1.27%5.17%7.94%
Upgrade
D&A For EBITDA
163.15165.14156.57156.01160.97147.63
Upgrade
EBIT
118.770.61-149.54-95.68117.36336.41
Upgrade
EBIT Margin
2.65%1.54%-3.16%-2.01%2.18%5.52%
Upgrade
Effective Tax Rate
38.74%33.94%-12.35%57.23%62.53%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.